Advances in Genetics-Based Medicine

Don’t be surprised if 2018 proves to be a big year for in good ways and bad.

While experts foresee trouble ahead for influenza and potential measles outbreaks, the areas of targeted breast cancer therapies, gene editing and migraine medicines offer new promise. The high price tag of some of the new therapies and technology will remain a concern for U.S. consumers. Here are some of the most intriguing health stories to watch for in 2018:

Article source:

Speak Your Mind